Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis

Aye Mu Myint, Yong Ku Kim

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

The involvement of immune system activation in the pathophysiology of certain psychiatric disorders is well documented. Inflammatory molecules such as pro-inflammatory cytokines could enhance the activity of the indoleamine 2,3-dioxygenase (IDO) enzyme which is the first rate-limiting enzyme of the tryptophan degradation pathway, the kynurenine pathway. The increased tryptophan degradation could induce serotonin depletion and depressive mood. On the other hand, the downstream metabolites from this pathway, such as 3-hydroxykynurenine, quinolinic acid and kynurenic acid, are neuroactive metabolites which can modulate several neurotransmissions, such as glutamatergic, GABAergic, dopaminergic and noradrenergic neurotransmissions, which in turn induce changes in neuronal-glial network and neuropsychiatric consequences. In this issue, we have revised the previous 'neurodegeneration hypothesis,' which explained the involvement of cytokines and IDO pathway interaction in depression, with a further extended view related to the network beyond IDO, the network between immune molecules, tryptophan metabolites and different neurotransmitters, in depression and other major psychiatric disorders such as schizophrenia, bipolar disorder and childhood psychiatric disorders.

Original languageEnglish
Pages (from-to)304-313
Number of pages10
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume48
DOIs
Publication statusPublished - 2014 Jan 3

Fingerprint

Indoleamine-Pyrrole 2,3,-Dioxygenase
Tryptophan
Psychiatry
Synaptic Transmission
Depression
Cytokines
Kynurenic Acid
Quinolinic Acid
Kynurenine
Enzymes
Bipolar Disorder
Neuroglia
Neurotransmitter Agents
Immune System
Serotonin
Schizophrenia

Keywords

  • Bipolar
  • Depression
  • Glutamate
  • IDO
  • Kynurenine
  • Schizophrenia

ASJC Scopus subject areas

  • Pharmacology
  • Biological Psychiatry

Cite this

Network beyond IDO in psychiatric disorders : Revisiting neurodegeneration hypothesis. / Myint, Aye Mu; Kim, Yong Ku.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 48, 03.01.2014, p. 304-313.

Research output: Contribution to journalArticle

@article{636fefbe4dbf48f1a97e7d141a010773,
title = "Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis",
abstract = "The involvement of immune system activation in the pathophysiology of certain psychiatric disorders is well documented. Inflammatory molecules such as pro-inflammatory cytokines could enhance the activity of the indoleamine 2,3-dioxygenase (IDO) enzyme which is the first rate-limiting enzyme of the tryptophan degradation pathway, the kynurenine pathway. The increased tryptophan degradation could induce serotonin depletion and depressive mood. On the other hand, the downstream metabolites from this pathway, such as 3-hydroxykynurenine, quinolinic acid and kynurenic acid, are neuroactive metabolites which can modulate several neurotransmissions, such as glutamatergic, GABAergic, dopaminergic and noradrenergic neurotransmissions, which in turn induce changes in neuronal-glial network and neuropsychiatric consequences. In this issue, we have revised the previous 'neurodegeneration hypothesis,' which explained the involvement of cytokines and IDO pathway interaction in depression, with a further extended view related to the network beyond IDO, the network between immune molecules, tryptophan metabolites and different neurotransmitters, in depression and other major psychiatric disorders such as schizophrenia, bipolar disorder and childhood psychiatric disorders.",
keywords = "Bipolar, Depression, Glutamate, IDO, Kynurenine, Schizophrenia",
author = "Myint, {Aye Mu} and Kim, {Yong Ku}",
year = "2014",
month = "1",
day = "3",
doi = "10.1016/j.pnpbp.2013.08.008",
language = "English",
volume = "48",
pages = "304--313",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Network beyond IDO in psychiatric disorders

T2 - Revisiting neurodegeneration hypothesis

AU - Myint, Aye Mu

AU - Kim, Yong Ku

PY - 2014/1/3

Y1 - 2014/1/3

N2 - The involvement of immune system activation in the pathophysiology of certain psychiatric disorders is well documented. Inflammatory molecules such as pro-inflammatory cytokines could enhance the activity of the indoleamine 2,3-dioxygenase (IDO) enzyme which is the first rate-limiting enzyme of the tryptophan degradation pathway, the kynurenine pathway. The increased tryptophan degradation could induce serotonin depletion and depressive mood. On the other hand, the downstream metabolites from this pathway, such as 3-hydroxykynurenine, quinolinic acid and kynurenic acid, are neuroactive metabolites which can modulate several neurotransmissions, such as glutamatergic, GABAergic, dopaminergic and noradrenergic neurotransmissions, which in turn induce changes in neuronal-glial network and neuropsychiatric consequences. In this issue, we have revised the previous 'neurodegeneration hypothesis,' which explained the involvement of cytokines and IDO pathway interaction in depression, with a further extended view related to the network beyond IDO, the network between immune molecules, tryptophan metabolites and different neurotransmitters, in depression and other major psychiatric disorders such as schizophrenia, bipolar disorder and childhood psychiatric disorders.

AB - The involvement of immune system activation in the pathophysiology of certain psychiatric disorders is well documented. Inflammatory molecules such as pro-inflammatory cytokines could enhance the activity of the indoleamine 2,3-dioxygenase (IDO) enzyme which is the first rate-limiting enzyme of the tryptophan degradation pathway, the kynurenine pathway. The increased tryptophan degradation could induce serotonin depletion and depressive mood. On the other hand, the downstream metabolites from this pathway, such as 3-hydroxykynurenine, quinolinic acid and kynurenic acid, are neuroactive metabolites which can modulate several neurotransmissions, such as glutamatergic, GABAergic, dopaminergic and noradrenergic neurotransmissions, which in turn induce changes in neuronal-glial network and neuropsychiatric consequences. In this issue, we have revised the previous 'neurodegeneration hypothesis,' which explained the involvement of cytokines and IDO pathway interaction in depression, with a further extended view related to the network beyond IDO, the network between immune molecules, tryptophan metabolites and different neurotransmitters, in depression and other major psychiatric disorders such as schizophrenia, bipolar disorder and childhood psychiatric disorders.

KW - Bipolar

KW - Depression

KW - Glutamate

KW - IDO

KW - Kynurenine

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84889095470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889095470&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2013.08.008

DO - 10.1016/j.pnpbp.2013.08.008

M3 - Article

C2 - 24184687

AN - SCOPUS:84889095470

VL - 48

SP - 304

EP - 313

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

ER -